Specification
| Modification | Cap1, m1Ψ |
| Length | 1277nt |
| Application | 1. Analytical or process development 2. In vitro or in vivo expression and distribution 3. Experimental control reference |
| Concentration | 1 mg/ml |
| Storage Buffer | 1mM Sodium citrate, pH6.5 |
| Storage Condition | -80℃ to - 65℃ |
| Shipping Condition | Blue Ice or Dry Ice |
Background
| Backround | This mRNA expresses the Sleeping Beauty transposase from the sequence originally described by Jin Z, et al. Gene Therapy. 2011. The Sleeping beauty transposon and transposase constitute a DNA plasmid system used for therapeutic human cell genetic engineering. This mRNA is capped with Cap1 structure for enhanced translation, and designed with a 100A tail to mimic mature mRNA. The sequence is 100% substituted with N1-methyl-pseudouridine or 5-Methoxyuridine for reduced immunogenicity and toxicity. |
QC Data
| Note | Please contact us for QC Data |
| Product Image (Reference Only) |  |